-
- 竹田 修三
- 第一薬科大学
書誌事項
- タイトル別名
-
- Medicinal Chemistry and Pharmacology Focused on Cannabidiol, a Major Component of the Fiber-Type <i>Cannabis</i>
- センイガタ タイマソウ シュセイブン カンナビジオール オ キバン ト シタ メディシナルケミストリー
- Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis
この論文をさがす
抄録
Considerable attention has focused on cannabidiol (CBD), a major non-psychotropic constituent of fiber-type cannabis plant, and it has been reported to possess diverse biological activities. Although CBD is obtained from non-enzymatic decarboxylation of its parent molecule, cannabidiolic acid (CBDA), several studies have investigated whether CBDA itself is biologically active. In the present report, the author summarizes findings indicating that; 1) CBDA is a selective cyclooxygenase-2 (COX-2) inhibitor, and ii) CBDA possesses an anti-migrative potential for highly invasive cancer cells, apparently through a mechanism involving inhibition of cAMP-dependent protein kinase A, coupled with an activation of the small GTPase, RhoA. Further, the author introduces recent findings on the medicinal chemistry and pharmacology of the CBD derivative, CBD-2′,6′-dimethyl ether (CBDD), that exhibits inhibitory activity toward 15-lipoxygenase (15-LOX), an enzyme responsible for the production of oxidized low-density lipoprotein (LDL). These studies establish CBD as both an important experimental tool and as a lead compound for pharmaceutical development. In this review, the author further discusses the potential uses of CBD and its derivatives in future medicines.<br>
収録刊行物
-
- 薬学雑誌
-
薬学雑誌 133 (10), 1093-1101, 2013-10-01
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282681104081792
-
- NII論文ID
- 130004427986
- 40019820459
-
- NII書誌ID
- AN00284903
-
- COI
- 1:STN:280:DC%2BC2c%2FlvVWgtg%3D%3D
-
- ISSN
- 13475231
- 00316903
-
- NDL書誌ID
- 024918872
-
- PubMed
- 24088353
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可